Literature DB >> 36267740

Exploring biomarkers and transcriptional factors in type 2 diabetes by comprehensive bioinformatics analysis on RNA-Seq and scRNA-Seq data.

Yalan Huang1, Linkun Cai2, Xiu Liu3, Yongjun Wu4, Qin Xiang5, Rong Yu1.   

Abstract

Background: Type 2 diabetes (T2D) is a prevalent chronic disease with elusive. Combining transcriptome and single-cell sequencing data to explore biomarkers of T2D could provide new insights into the in-depth understanding of the molecular mechanisms and diagnosis of T2D.
Methods: The GSE41762 dataset including RNA-seq data for healthy and T2D patients, was obtained from the Gene Expression Omnibus (GEO) database. The potential functions of the differentially expressed genes (DEGs) were revealed by Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) analysis. Moreover, biomarkers were screened out by the Least Absolute Shrinkage and Selection Operator (LASSO) algorithm and receiver operating characteristic (ROC) analysis. Furthermore, single-cell RNA (sc-RNA)-seq data in the "E-MTAB-5061" dataset was downloaded from the ArrayExpress (European Bioinformatics Institute, EBI) database. Principal components analysis (PCA) and t-distributed stochastic neighbor embedding (tSNE) were used for dimensionality reduction analysis and cell clustering. The FindAllMarkers function was used annotate different cell clusters, and key cell clusters were screened by the expression levels of the biomarkers. Finally, the transcription factors (TFs) of the biomarkers were recognized.
Results: A total of 111 DEGs were screened in the GSE41762 dataset, which were mainly related to hormone secretion, specialized postsynaptic membrane, pancreatic secretion, JAK-STAT signaling pathway, and Ras signaling pathway. In addition, SLC2A2, SERPINF1, RASGRP1, and CHL1 were screened out as biomarkers of T2D, which possessed potential diagnostic value as AUC value greater than 0.8. A total of 1,515 T2D group cells and 1,817 healthy cohort cells were screened as core cells in the "E-MTAB-5061" dataset. Following tSNE dimensionality reduction cluster analysis, the core cells were divided into 13 cell clusters. According to the marker genes, the 13 cell clusters were annotated into six types of cells. Notably, SERPINF1 was highly expressed in fibroblasts and might be regulated by NR2F2 (nuclear receptor subfamily2, group F, and member 2). Conclusions: This study identified four biomarkers (SLC2A2, SERPINF1, RASGRP1, and CHL1) for T2D, which provided new markers for the clinical diagnosis of T2D. Among them, SERPINF1 might be regulated by NR2F2, which provides valuable insight into the pathogensis of T2D. 2022 Annals of Translational Medicine. All rights reserved.

Entities:  

Keywords:  RNA-seq; Type 2 diabetes (T2D); biomarkers; single-cell RNA (sc-RNA)-seq; transcription factors (TFs)

Year:  2022        PMID: 36267740      PMCID: PMC9577746          DOI: 10.21037/atm-22-4303

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN: 2305-5839


  35 in total

1.  SLC2A2 mutations can cause neonatal diabetes, suggesting GLUT2 may have a role in human insulin secretion.

Authors:  F H Sansbury; S E Flanagan; J A L Houghton; F L Shuixian Shen; A M S Al-Senani; A M Habeb; M Abdullah; A Kariminejad; S Ellard; A T Hattersley
Journal:  Diabetologia       Date:  2012-06-02       Impact factor: 10.122

2.  CalDAG-GEFIII activation of Ras, R-ras, and Rap1.

Authors:  S Yamashita; N Mochizuki; Y Ohba; M Tobiume; Y Okada; H Sawa; K Nagashima; M Matsuda
Journal:  J Biol Chem       Date:  2000-08-18       Impact factor: 5.157

3.  RasGRP, a Ras guanyl nucleotide- releasing protein with calcium- and diacylglycerol-binding motifs.

Authors:  J O Ebinu; D A Bottorff; E Y Chan; S L Stang; R J Dunn; J C Stone
Journal:  Science       Date:  1998-05-15       Impact factor: 47.728

4.  RasGRP1 is a target for VEGF to induce angiogenesis and involved in the endothelial-protective effects of metformin under high glucose in HUVECs.

Authors:  Jing Xu; Miao Liu; Muqiao Yu; Jiayi Shen; Jiecan Zhou; Jinglei Hu; Yong Zhou; Wei Zhang
Journal:  IUBMB Life       Date:  2019-05-23       Impact factor: 3.885

Review 5.  The biological and pharmacological connections between diabetes and various types of cancer.

Authors:  Xuechang Wang; Suming Ding
Journal:  Pathol Res Pract       Date:  2021-09-29       Impact factor: 3.250

6.  Co-expression Network Revealed Roles of RNA m6A Methylation in Human β-Cell of Type 2 Diabetes Mellitus.

Authors:  Cong Chen; Qing Xiang; Weilin Liu; Shengxiang Liang; Minguang Yang; Jing Tao
Journal:  Front Cell Dev Biol       Date:  2021-05-18

7.  Boosting scRNA-seq data clustering by cluster-aware feature weighting.

Authors:  Rui-Yi Li; Jihong Guan; Shuigeng Zhou
Journal:  BMC Bioinformatics       Date:  2021-06-02       Impact factor: 3.307

Review 8.  Legume genomics and transcriptomics: From classic breeding to modern technologies.

Authors:  Muhammad Afzal; Salem S Alghamdi; Hussein H Migdadi; Muhammad Altaf Khan; Shaher Bano Mirza; Ehab El-Harty
Journal:  Saudi J Biol Sci       Date:  2019-11-25       Impact factor: 4.219

9.  SCENIC: single-cell regulatory network inference and clustering.

Authors:  Sara Aibar; Carmen Bravo González-Blas; Thomas Moerman; Vân Anh Huynh-Thu; Hana Imrichova; Gert Hulselmans; Florian Rambow; Jean-Christophe Marine; Pierre Geurts; Jan Aerts; Joost van den Oord; Zeynep Kalender Atak; Jasper Wouters; Stein Aerts
Journal:  Nat Methods       Date:  2017-10-09       Impact factor: 28.547

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.